spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  CVRx 

 HSMN NewsFeed - 25 Jan 2019
Functional Neuromodulation Announces CEO Leadership Transition
Devices Neurology Personnel
 HSMN NewsFeed - 9 Aug 2016
CVRx(R) Secures $113 Million in New Financing
Devices Venture Capital
 HSMN NewsFeed - 19 Nov 2015
CVRx(R) Announces Expedited Access Pathway Designation By FDA for Barostim Therapy(R) for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients
Devices Cardiology FDA
 HSMN NewsFeed - 26 May 2015
CVRx(R) Barostim Therapy(R) for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference
Devices Cardiology
 HSMN NewsFeed - 17 Mar 2015
CVRx(R) Barostim Therapy(TM) for Heart Failure Clinical Trial Results Presented in a Featured Clinical Research Session of the American College of Cardiology Annual Conference
Devices Cardiology
 HSMN NewsFeed - 16 Dec 2014
CVRx(R) Granted Humanitarian Device Exemption Approval from FDA for Barostim neo legacy(TM) Hypertension Therapy Device
Devices Cardiology FDA
 HSMN NewsFeed - 11 Dec 2014
CVRx(R) Granted CE Marking of the Barostim neo System(TM) for Conditional MRI Compatibility
Devices Cardiology Regulatory
 HSMN NewsFeed - 7 Jan 2014
Barostim Therapy(TM) Projected to be Cost-Effective in Treating Resistant Hypertension
Devices Cardiology
 HSMN NewsFeed - 5 Nov 2013
CVRx(R) & DaVita Announce Strategic Partnership
Devices
 HSMN NewsFeed - 30 Oct 2013
CVRx Closes $12 Million Additional Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 9 Jul 2012
CVRx(R) Names Philippe Wanstok Chief Commercial Officer
Devices Cardiology Personnel
 HSMN NewsFeed - 25 Aug 2011
CVRx(R) Receives CE Mark Approval and Introduces New Implantable Device for Hypertension, the Barostim neo(TM)
Devices Cardiology Regulatory
 HSMN NewsFeed - 21 Jun 2010
Four-Year Clinical Study Findings Show Significant and Persistent Reduction in Blood Pressure with Rheos(R) System
Devices
 HSMN NewsFeed - 30 Mar 2009
Longer-Term Clinical Trial Findings Show Significant Reduction in Blood Pressure, Improvement in Heart Function with CVRx Rheos System
Devices Cardiology
 HSMN NewsFeed - 23 Sep 2008
Clinical Data Show CVRx(R) Rheos(R) Therapy Improved Heart Structure and Function in Early-Stage Heart Failure Patients
Devices Cardiology
 HSMN NewsFeed - 30 Jul 2008
CVRx(R), Inc. Closes $84 Million Financing
Devices Venture Capital
 HSMN NewsFeed - 18 Jun 2008
Two-Year Clinical Trial Findings Show Significant and Persistent Reduction in Blood Pressure with CVRx(R) Rheos(R) Hypertension Therapy
Devices
 HSMN NewsFeed - 28 Apr 2008
New Implantable Device Designed to Lower High Blood Pressure May Offer Hope for Millions of Patients
Devices Cardiology
 HSMN NewsFeed - 31 Oct 2007
CVRx(R), Inc. Receives CE Mark Approval for Rheos(R) Baroreflex Hypertension Therapy(TM) System
Devices Cardiology FDA
 HSMN NewsFeed - 11 Jul 2007
Medical Device Company CVRx Adopts Configurable ARC(R) Core For Implantable Blood Pressure Reduction Device
Devices Cardiology
 HSMN NewsFeed - 17 May 2007
CVRx(R), Inc. Appoints Todd Langevin Senior Vice President of Clinical and Commercial Development
Devices Personnel
 HSMN NewsFeed - 25 Mar 2007
European and U.S. Clinical Trial Findings Show Significant Reduction in Blood Pressure with CVRx(R) Rheos(TM) Baroreflex Hypertension Therapy(TM) System
Devices Cardiology
 HSMN NewsFeed - 16 Oct 2006
CVRx(R), Inc., Receives IDE Approval for Rheos(TM) Baroreflex Hypertension Therapy(TM) System Pivotal Trial
Devices FDA
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.